The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 05, 2024

Filed:

Dec. 11, 2019
Applicant:

Omrix Biopharmaceuticals Ltd., Rehovot, IL;

Inventors:

Israel Nur, Nes-Ziona, IL;

Elena Grimberg, Rehovot, IL;

Itai Podoler, Rehovot, IL;

Inbar Gahali-Sass, Mazkeret Batya, IL;

Erez Ilan, Kibbutz Netzer Sereni, IL;

Ronen Eavri, Binyamina, IL;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 9/08 (2006.01); A61K 33/06 (2006.01); A61K 38/36 (2006.01); A61K 38/37 (2006.01); A61K 38/38 (2006.01); A61K 38/48 (2006.01); A61P 7/04 (2006.01); A61P 41/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/363 (2013.01); A61K 9/08 (2013.01); A61K 33/06 (2013.01); A61K 38/366 (2013.01); A61K 38/37 (2013.01); A61K 38/38 (2013.01); A61K 38/4833 (2013.01); A61P 7/04 (2018.01); A61P 41/00 (2018.01); C12Y 304/21005 (2013.01);
Abstract

Provided herein are kits comprised of a first container including a solution of fibrinogen-containing component that includes fibrinogen at a concentration range of about 5 mg/ml to about 30 mg/ml, and having a total protein concentration range of about 15 mg/ml to about 40 mg/ml; and a second container that includes a solution of thrombin-containing component. Further provided are mixtures comprised of fibrinogen and thrombin, calcium ions, and albumin, the mixture being comprised of total protein in a range of about 2.5 mg/ml to about 30 mg/ml, fibrinogen in a range of about 50% to about 80% of total protein, and albumin in a range of more than 0.65 mg/ml to about 3 mg/ml. Further provided herein are methods for preventing or reducing tissue adhesion, and hydrogel materials made of fibrin.


Find Patent Forward Citations

Loading…